James Armitage
Net worth: 52 231 $ as of 2026-05-30
Net worth: 52 231 $ as of 2026-05-30
Dr. James O.
Armitage, MD, is an Independent Director at Cardiff Oncology, Inc. and a Professor-Internal Medicine at University of Nebraska Medical Center.
He is on the Board of Directors at Cardiff Oncology, Inc. and Tesaro, Inc. Dr. Armitage was previously employed as a President by American Society for Blood & Marrow Transplantation and a President & Director by American Society of Clinical Oncology, Inc. He also served on the board at MGI PHARMA, Inc. He received his undergraduate degree from the University of Nebraska and a doctorate degree from the University of Nebraska Medical Center.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 27,490 ( 0.04% ) | 52 231 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| TESARO INC | Director/Board Member | 2013-05-08 |
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 2020-04-21 |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1981-12-31 |
| Companies | Position | End |
|---|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Director/Board Member | 2008-01-28 |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | President | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. |
Select your edition
All financial news and data tailored to specific country editions